unknown
Stage
1
Investors
About
Fulcrum Therapeutics is a clinical-stage biopharmaceutical company developing small-molecule therapeutics that modulate gene expression to treat genetically defined rare diseases. Its lead clinical program is pociredir, aimed at addressing the root causes of gene mis-expression in relevant patient populations.
Explore Fulcrum Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.